What are all the things that aspirin does?
作者信息
Flower Rod
出版信息
BMJ. 2003 Sep 13;327(7415):572-3. doi: 10.1136/bmj.327.7415.572.
Abstract
摘要
相似文献
1
What are all the things that aspirin does?阿司匹林都有哪些作用？
BMJ. 2003 Sep 13;327(7415):572-3. doi: 10.1136/bmj.327.7415.572.
2
Aspirin and its rivals. As your options increase, your choices get harder.阿司匹林及其同类药物。随着选择增多，抉择愈发艰难。
Harv Mens Health Watch. 2002 Dec;7(5):1-5.
3
[A 100 years of aspirin: a drug with a future?].[阿司匹林百年：一种拥有未来的药物？]
An R Acad Nac Med (Madr). 1997;114(1):157-63; discussion 164-7.
4
Aspirin resistance: does it exist and is it an important clinical problem?阿司匹林抵抗：它是否存在，是否是一个重要的临床问题？
Clin Adv Hematol Oncol. 2006 Apr;4(4):268-70.
5
Cardioprotective effects of aspirin compromised by other NSAIDs.阿司匹林的心脏保护作用被其他非甾体抗炎药削弱。
BMJ. 2003 Sep 6;327(7414):520. doi: 10.1136/bmj.327.7414.520.
6
[Aspirin. A wonder drug?].[阿司匹林。一种神奇的药物？]
Invest Clin. 1997 Jun;38(2):59-61.
7
Cyclooxygenase inhibition in patients with coronary artery disease.冠状动脉疾病患者的环氧化酶抑制作用。
J Am Coll Cardiol. 2004 Feb 18;43(4):532-3. doi: 10.1016/j.jacc.2003.11.018.
8
The coxibs, selective inhibitors of cyclooxygenase-2.昔布类药物，环氧化酶-2的选择性抑制剂。
N Engl J Med. 2001 Dec 6;345(23):1709.
9
Efficacy and safety of aspirin in the long-term management of atherothrombosis.阿司匹林在动脉粥样硬化血栓形成长期管理中的疗效与安全性。
Haematologica. 2002 Jan;87(1):6-8.
10
Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis.阿司匹林抗血小板治疗与非甾体抗炎药：对美国风湿病学会2002年类风湿关节炎管理指南更新版的评论
Arthritis Rheum. 2002 Nov;46(11):3102. doi: 10.1002/art.10505.
引用本文的文献
1
Increased platelet activation and thrombo-inflammation in early and late-onset preeclampsia.早发型和晚发型子痫前期中血小板活化增加及血栓炎症反应
Res Pract Thromb Haemost. 2025 Jun 24;9(5):102956. doi: 10.1016/j.rpth.2025.102956. eCollection 2025 Jul.
2
The cyclooxygenase-expressing mesenchyme resists intestinal epithelial injury by paracrine signaling.表达环氧化酶的间充质通过旁分泌信号传导抵抗肠道上皮损伤。
Cell Regen. 2023 Aug 14;12(1):30. doi: 10.1186/s13619-023-00174-7.
3
Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management.冠状动脉疾病与阿司匹林不耐受：背景及当前管理见解
Cardiol Ther. 2022 Jun;11(2):175-183. doi: 10.1007/s40119-022-00255-9. Epub 2022 Mar 28.
4
From NSAIDs to Glucocorticoids and Beyond.从 NSAIDs 到糖皮质激素，以及更多。
Cells. 2021 Dec 14;10(12):3524. doi: 10.3390/cells10123524.
5
Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships.从药物-靶点和药物不良反应数据库中挖掘以识别靶点-药物不良反应关系。
Database (Oxford). 2021 Oct 20;2021. doi: 10.1093/database/baab068.
6
Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells the NF-κB Signaling Pathway.阿司匹林通过抑制树突状细胞的成熟和NF-κB信号通路减轻心脏移植排斥反应。
Front Pharmacol. 2021 Aug 16;12:706748. doi: 10.3389/fphar.2021.706748. eCollection 2021.
7
Lipids and Antiplatelet Therapy: Important Considerations and Future Perspectives.脂质与抗血小板治疗：重要考虑与未来展望。
Int J Mol Sci. 2021 Mar 20;22(6):3180. doi: 10.3390/ijms22063180.
8
Colorectal Cancer Is Associated with a Deficiency of Lipoxin A, an Endogenous Anti-inflammatory Mediator.结直肠癌与内源性抗炎介质脂氧素A缺乏有关。
J Cancer. 2019 Aug 20;10(19):4719-4730. doi: 10.7150/jca.32456. eCollection 2019.
9
Pharmacologically pertinent period of effect (PPPE).药效持续期（PPPE）。
Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):61-67. doi: 10.1002/pds.4714. Epub 2019 Jan 9.
10
Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation.格拉普兰特：一种EP4前列腺素受体拮抗剂及治疗疼痛和炎症的新型疗法。
Vet Med Sci. 2015 Dec 21;2(1):3-9. doi: 10.1002/vms3.13. eCollection 2016 Feb.
本文引用的文献
1
Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.阿司匹林/非甾体抗炎药与食管癌的保护关联：一项系统评价和荟萃分析。
Gastroenterology. 2003 Jan;124(1):47-56. doi: 10.1053/gast.2003.50008.
2
Aspirin and cancer risk: an update to 2001.阿司匹林与癌症风险：2001年最新进展
Eur J Cancer Prev. 2002 Dec;11(6):535-42. doi: 10.1097/00008469-200212000-00005.
3
NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.核因子κB介导白细胞介素-1β诱导的人神经胶质细胞系中α2-巨球蛋白的合成/释放。
Brain Res Mol Brain Res. 2002 Sep 30;105(1-2):108-14. doi: 10.1016/s0169-328x(02)00398-4.
4
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.COX-3，一种受对乙酰氨基酚和其他止痛/退烧药抑制的环氧化酶-1变体：克隆、结构与表达
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31. doi: 10.1073/pnas.162468699. Epub 2002 Sep 19.
5
Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents.一氧化氮释放药物：一类新型的有效且安全的治疗药物。
Ann N Y Acad Sci. 2002 May;962:360-71. doi: 10.1111/j.1749-6632.2002.tb04080.x.
6
Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.非甾体抗炎药作为抗癌药物：作用机制、药理学及临床问题
J Natl Cancer Inst. 2002 Feb 20;94(4):252-66. doi: 10.1093/jnci/94.4.252.
7
Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer.水杨酸：阿司匹林、饮食与结直肠癌预防之间的联系。
QJM. 2001 Aug;94(8):445-8. doi: 10.1093/qjmed/94.8.445.
8
Anti-inflammatory drugs protect against Alzheimer disease at low doses.
Arch Neurol. 2000 Nov;57(11):1586-91. doi: 10.1001/archneur.57.11.1586.
9
Risk of Alzheimer's disease and duration of NSAID use.阿尔茨海默病风险与非甾体抗炎药使用时长
Neurology. 1997 Mar;48(3):626-32. doi: 10.1212/wnl.48.3.626.
10
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.非甾体抗炎药作为组成型和诱导型环氧化酶抑制剂的选择性
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693-7. doi: 10.1073/pnas.90.24.11693.
Zotero 插件